Microarray Analysis Market Research Report—Forecast till 2027

Microarray Analysis Market: By Product& Services (Consumables, Software and Services, Others), By Type (DNA Microarrays, Protein Microarrays), By Application (Drug discovery, Disease Diagnostic, Research Applications), By End User (Research and Academic Institutes, Pharmaceutical and Biotechnology Companies, Diagnostic Laboratories), and by Region (Americas, Europe, Asia-Pacific, and Middle East & Africa)—Forecast till 2027

ID: MRFR/HC/0293-CR | August 2021 | Region: Global | 166 pages

Microarray Analysis Market Forecast


The microarray analysis market is expected to cross USD 6,607.64 million by 2027 at a CAGR of 7.76%.  


Microarray Analysis Market Overview:


Microarray is a powerful approach used to analyze gene expression in various experimental purposes. Numerous microarray platforms are available for testing. The development of microarrays had improved the results of genetic testing.


The global microarrays analysis market is majorly driven by the high prevalence of cancer and the rising need for research in pharmaceutical industries. The increasing prevalence of different chronic diseases, use of this technique to diagnose infectious diseases, development in the field of genetics, and increasing healthcare expenditure have provided a push to themarket.However, the high cost of tests and the need for high-tech instruments may restrain the growth of microarray analysis market.


COVID-19 Analysis Of Microarray Analysis Market 


The COVID-19 pandemic has disrupted the global supply chain and interrupted the entire value chain of the global microarray analysis market, from raw material procurement to manufacturing, packaging, and distribution.With several manufacturers having the required raw material and end-product stock, the impact does not seem high for a short duration. However, if the pandemic prolongs and trade restrictions are extended, the impact is expected to rise.COVID-19 can affect the global economy in three main ways:directly impacting production and demand, causing supply chain and market disruption, and having a financial impact on businesses and financial markets.The pandemic has resulted in new product approval through Emergency Use Authorization (EUA) status. On 9th June 2020, the US FDA issued a EUA for the Illumina COVIDSeq Test, a high-throughput, sequencing-based, in vitro diagnostic workflow enabling the detection of SARS-CoV-2.The growing applications of microarray technology and the increasing patient population suffering from various diseases are anticipated to increase the demand for testing and research.


Microarray Analysis Market Dynamics:


Drivers:



  • Growing application area of microarrays:


Best known for their use in screening, DNA microarrays have also advanced the pace of disease research. Theydetect differences between healthy control tissue and cancerous tissue. A large number of applications of microarrays are anticipated to increase the need for products used in the analysis. cDNA microarrays can only be used for gene expression analysis, but oligonucleotide microarrays can be utilised for both mutation-genotyping and gene expression analysis.



  • Increasing incidence of cancer:

  • Funding for genomic and proteomic research:


Restraints


  • Presence of substitutes and lack of skilled professionals:


The availability of substitutes and the presence of alternate mediums for the analysis hinder the growth of the microarray analysis market. For example, RNA-sequencing allows for full sequencing of the whole transcriptome, while microarray analysis only profiles predefined transcripts/genes through hybridization. Moreover, the lack of skilled professionals and the need for standardization of databases are some of the factors hampering the growth of the market.


Opportunities:



  • New product launch in developing markets:


The increasing development in the diagnosis and treatment option has led to the development of products that can help patients for a large application. A book published in 2018, Genomic Medicine in Emerging Economies,demonstrates how advances in medical science have already transformed health systems and led to improved patient care in Indonesian, Chilean, Malaysian, Argentinian, Chinese, Sri Lankan, and Colombian populations. With changingexternal business environment due to increasing demand from researchers and clinicians, major players, such as Thermo Fisher Scientific Inc., Agilent Technologies Inc., Illumina, and Bio-Rad Laboratories, Inc., have launched new products in recent years.


Value Chain Analysis


The global microarray analysis market is growing steadily and is expected to continue growing at the same rate in the near future. This is due to the growing contribution of existing players to make the product more effective. The supply chain analysis for the microarray analysis market comprises four major components, which start with the research and product development (R&D) followed by manufacturing of the products, distribution & sales, and ends with post-sales monitoring.


Global Microarray Analysis Market Share (%),By Product & Services, 2019
Global Microarray Analysis Market Share (%),By Product & Services, 2019
Source: MRFR Analysis


Microarray Analysis Market Segment Overview:


By Product & Services



  • Consumables


Consumables are used for the microarrays are slides, functionalized glass slides, plastic slides, and functionalized cover slides. These consumables find applications in the microarray techniques and are used for the scanning of the genes. A rise in the number of diagnostic laboratories and research institutes has led to a rise in the demand for consumables. Moreover, the rise in the number of DNA methylation and mRNA studies has led to the rise in the adoption of consumables for microarrays



  • Software and Services


Microarray services and software are used for the analysis and identification of genomes. The data is analyzed using the software. The rise in the experiments has increased the adoption of tools and services which contributes for the demand for the software and services. Rising demand for the determination and characterization of the human proteins has led to the adoption of the services and software for microarrays, thereby contributing to microarray analysis market growth.



  • Instruments


Several tools are used for the analysis of microarrays, including microarray ovens, that find applications for the analysis of the genes and are one of the major factors boosting the demand for the instruments. Chips, plates, and forceps are some of the instruments that find applications in microarrays. The wide availability of chips and plates and rise in the adoption of new technologies contributes to the high demand for instruments


By Type



  • DNA Microarrays


DNA microarrays are used to detect mutations in a specific gene’s DNA structure and can be used to diagnose diseases and genetic disorders. Rising prevalence of cancer is one of the factors, that contributes to the demand for DNA microarrays. According to the World Health Organization in 2018, around 1.8 million people are expected to be diagnosed with cancer. Additionally, in 2020, according to the American Cancer Society 45% of new cases were diagnosed in the US



  • Protein Microarrays


Protein chips or protein microarrays are used for the determination and analysis of the interactions of the proteins. Increased spending on research and development activities is also one of the factors, likely to contribute to the rising demand for protein microarrays. According to the National Science Foundation, the funding for research & development increased from USD 61 billion in 2017 to 63 billion in 2018



  • Others


Some of the other types of microarrays consist of MM chips, tissue microarrays, antibody microarrays, carbohydrate microarrays, and peptide microarrays.


By Application



  • Drug Discovery


Drug discovery is defined as a technique, which finds its application in the determination and the analysis of drugs. There are four stages in the drug discovery process: phase I, phase II, phase III, and phase IV. According to the American Society of Council and Health, in 2018, the 13.8% of the molecules, which are tested are successful. Rising research & development has led to the rise in the number of clinical trials, which are some of the factors contributing to the microarray analysis market growth



  • Disease Diagnostics


Microarrays are widely used in the diagnosis and analysis of molecules. The rise in the prevalence of chronic diseases has led to the rise in the demand for disease diagnostic. Cardiovascular diseases (CVDs) are the number 1 cause of deaths globally, taking an estimated 17.9 million lives each year



  • Research Applications


Research applications are used for the analysis and determination and diagnosis of diseases. DNA molecules are diagnosed using microarrays and help in the determination of the progress of the diseases. The accuracy of the detection of the mutations is high using the microarrays and is one of the major factors contributing to the demand for microarrays



  • Others


Microarrays also find applications in the determination of genes, pathogens, genomics, proteomics, and toxicology research. They are also used in the food industry for the analysis and determination of the pathogens. The RNA of the microbes is studied in the food industry


By Application




  • Research & Academic Institutes



Academic and research institutes are defined as organizations, which conduct several studies on several subjects. The studies on human genome projects have increased in the past few years. The rise in funding for research projects is majorly contributing to the growth of the research and academic institutes. Rising funding for research projects has also led to the rise in the academic research institutes, thereby boosting the growth of the microarray analysis market segment.


  • Pharmaceutical & Biotechnology Companies


Pharmaceutical and biotechnology companies are the organizations that develop and manufacture drugs. Several research programs are conducted by the pharmaceutical and biotechnology companies for the diagnosis and development of new drugs. Medical products are manufactured, after the research studies are completed by the biotechnology and pharmaceutical companies



  • Diagnostic Laboratories


Diagnostic laboratories are used for the analysis and the detection of diseases. The rise in the prevalence of diseases has led to the adoption of microarray analysis. Several diagnostic laboratories relate to hospitals, which contributes to the demand for diagnostic laboratories



  • Others


Microarrays are also used in forensic centers, hospitals, contract research organizations, and DNA & gene chip manufacturers. Several drugs are manufactured by contract research organizations. Microarrays are widely used for the analysis and determination of the mutation of the molecules. The molecules are screened using the microarray techniques and are widely used in several contract research organizations


Global Microarray Analysis Market Share (%), by Region, 2019
Global Microarray Analysis Market Share (%), by Region, 2019
Source: MRFR Analysis


Microarray Analysis Market Regional Analysis


The global microarray analysismarket, based on region, has been divided into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.



  • Americas


In 2019, the Americas accounted for the largest market share of 40.98% and were estimated to dominate the global microarray analysis market throughout the forecast period. This largest market share can be attributed to the increasing adoption of new technologies and the presence of major players in the region. The Americas is further categorized into North America and Latin America.


The North America market comprises the US and Canada. The increasing prevalence of cancer and the rise in funding for research and development in this region are key factors supporting the growth of the microarray analysis market in North America. For instance, in 2019, the National Institute of Cancer received funding of around USD 42.1 for cancer research. Microarrays are used for the identification of cancer cells and the determination of the genetic structure of the cell. Moreover, the rise in the demand for new drugs has led to increased funding for proteomics and genomics, thereby contributing to microarray analysis market growth.



  • Europe


Europe holds a healthy share in the global microarray analysis market and is the second-largest market after the Americas, owing to the highly developed healthcare industry, prominent research & development infrastructure, and accessibility of products. The European microarray analysis market is segmented into Western Europe and Eastern Europe. Western Europe is further segmented into Germany, France, the UK, Spain, Italy, and the Rest of Western Europe. The microarray market in Europe is expected to propel owing to factors such as the prevalence of cancer and several chronic diseases in the region.



  • Asia-Pacific


The microarray analysis market in Asia-Pacific is segmented into China, Japan, India, the Republic of Korea, Australia, and the Rest of Asia-Pacific. This regional market is anticipated to be the second fastest-growing globally due to the growing geriatric population and increasing prevalence of chronic diseases and cancer, which led to the adoption of precision medicines.



  • Middle East & Africa


The Middle East & Africa microarray analysis market is expected to depict the least share in the market throughout the forecast period owing to factors such as underdeveloped research, lack of awareness among consumers, and low disposable income facilities in African countries. The rising prevalence of cancer in the Middle East is one of the major factors for the adoption of microarrays for research and development. However, the global microarray analysis market in Africa is expected to grow slowly owing to underdeveloped healthcare facilities and a lack of research facilities in Africa.


Competitive Landscape


The global microarray analysis market is characterized by the presence of many global, regional, and local vendors catering to the demand for microarray. The availability of innovative products is increasing the lucrativeness of the global microarray analysis market. The key players have adopted the strategy of signing contracts and agreements for expanded regional reach and optimized operational costs. The market is highly competitive, with players competing and partnering to gain a substantial market share. The global microarray analysis market is highly fragmented with rising competition, product launches, collaborative partnerships, and other strategic decisions that are undertaken to achieve operational efficiency.


List of Key Companies Covered in Microarray Analysis Market Report:


  • Agilent Technologies (US)

  • Bio-Rad Laboratories (US)

  • Illumina (US)

  • Thermo Fisher Scientific (US)

  • Microarrays, Inc. (US)

  • PerkinElmer, Inc. (US)

  • Merck KGaA (Germany)

  • GE Healthcare (US)

  • Danaher Corporation (US)

  • Arrayit Corporation (US)


Recent Developments


Some of the key strategies followed by players operating in the microarray analysis market were product launches, collaborative partnerships, acquisitions, and expansions.



  • In June 2020, Thermo Fisher Scientific launched the Axiom Human Genotyping SARS-CoV-2 Research Array, which will help epidemiologists to study the SARS-CoV-2 infectious disease.

  • In April 2020,Bio-Rad acquired Celsee, Inc. helped improve the company's capabilities in single-cell isolation, detection, and analysis.

  • In August 2019, Agilent Technologies, Inc. acquired Lionheart Technologies LLC ("BioTek"), a recognized global leader in the design, manufacturing, and distribution of innovative life science instrumentation. Its comprehensive product line includes cell imaging systems, microplate readers, washers, dispensers, automated incubators, and stackers.


Microarray Analysis Market Report Overview:


The study covers the existing short-term and long-term market effects, helping decision-makers to draught short-term and long-term plans for businesses by region. The report covers major regions in the Americas, Europe, Asia-Pacific, and Middle East & Africa. The report analyzes market drivers, restraints, opportunities, challenges, Porter's five forces, value chain, and impact of COVID-19 on the microarray analysis market.

Microarray Analysis Market Scope of the Report & Segmentation


The scope of the global microarray analysis market study includes the market size analysis and a detailed analysis of the manufacturer's products and strategies. The market has been segmented based on product & service, type, application, end user, and region.


Global Microarray Analysis Market, By Product &Services



  • Consumables

  • Software and Services

  • Instruments


Global Microarray Analysis Market, By Type



  • DNA Microarrays

  • Protein Microarrays

  • Others


Global Microarray Analysis Market, By Application



  • Drug Discovery

  • Disease Diagnostics

  • Research Applications

  • Others


Global Microarray Analysis Market, By End User



  • Research & Academic Institutes

  • Pharmaceutical & Biotechnology Companies

  • Diagnostic Laboratories

  • Others


Global Microarray Analysis Market, By Region



  • Americas

    • North America

      • US

      • Canada



    • Latin America

      • Brazil

      • Mexico

      • Rest of Latin America





  • Europe

    • Western Europe

      • Germany

      • France

      • UK

      • Italy

      • Spain

      • Rest of Europe



    • Eastern Europe



  • Asia-Pacific

    • China

    • Japan

    • India

    • Australia

    • South Korea

    • Rest of Asia-Pacific



  • Middle East & Africa

    • Middle East

    • Africa





Report Scope:
Report Attribute/Metric Details
  Market Size   2027: USD 6,607.64 Million
  CAGR   2027: 7.76%
  Base Year   2019
  Forecast Period   2020-2027
  Historical Data   2017 & 2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Product & Services, Type, Application, End User, and Region
  Geographies Covered   Americas, Europe, Asia-Pacific, Middle East & Africa
  Key Vendors   Agilent Technologies (US), Bio-Rad Laboratories (US), Illumina (US), Thermo Fisher Scientific (US), Microarrays, Inc. (US), PerkinElmer, Inc. (US), Merck KGaA (Germany), GE Healthcare (US), Danaher Corporation (US), Arrayit Corporation (US)
  Key Market Opportunities   New product launch in developing markets
  Key Market Drivers

  • Growing application area of microarrays
  • Increasing incidence of cancer
  • Funding for genomic and proteomic research


  • Speak to Analyst Ask for Customization

    Frequently Asked Questions (FAQ) :


    Rising demand for personalized medicine, focus on drug discovery, and prevalence of genetic disorders are major drivers of the Global Microarray Analysis Market.

    Probability of inaccurate results and skyrocketing costs of diagnosis and contamination can deter the Global Microarray Analysis Market.

    Heavy investments in cancer research and high prevalence of cancer are prime growth opportunities for the Global Microarray Analysis Market.

    Americas is the dominant region of the Global Microarray Analysis Market due to awareness of better diagnostic tests.

    Thermo Fisher Scientific, NextGen Sciences, PLC, Applied Microarrays, Agilent Technologies, Inc., Luminex Corporation, Roche NimbleGen, Gyros AB, Affymetrix, Inc., ProteoGenix, Discerna, Illumnia, Inc., bioMérieux SA, and Sequenom, Inc. are major players of the Global Microarray Analysis Market.

    TABLE OF CONTENTS

    1 EXECUTIVE SUMMARY

    2 MARKET INTRODUCTION

    2.1 DEFINITION

    2.2 SCOPE OF THE STUDY

    2.3 RESEARCH OBJECTIVE

    2.4 MARKET STRUCTURE

    2.5 ASSUMPTIONS & LIMITATIONS

    3 RESEARCH METHODOLOGY

    3.1 DATA MINING

    3.2 SECONDARY RESEARCH

    3.3 PRIMARY RESEARCH

    3.4 BREAKDOWN OF PRIMARY RESPONDENTS

    3.5 FORECASTING TECHNIQUES

    3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION

    3.6.1 BOTTOM-UP APPROACH

    3.6.2 TOP-DOWN APPROACH

    3.7 DATA TRIANGULATION

    3.8 VALIDATION

    4 MARKET DYNAMICS

    4.1 OVERVIEW

    4.2 DRIVERS

    4.2.1 GROWING APPLICATION AREAS OF MICROARRAYS

    4.2.2 INCREASING INCIDENCE OF CANCER

    4.2.3 FUNDING FOR GENOMIC AND PROTEOMIC RESEARCH

    4.3 RESTRAINTS

    4.3.1 PRESENCE OF SUBSTITUTES AND LACK OF SKILLED PROFESSIONALS

    4.4 OPPORTUNITIES

    4.4.1 NEW PRODUCT LAUNCH IN DEVELOPING MARKETS

    5 MARKET FACTOR ANALYSIS

    5.1 VALUE CHAIN ANALYSIS

    5.1.1 R&D

    5.1.2 MANUFACTURING

    5.1.3 DISTRIBUTION AND SALES

    5.1.4 POST-SALES MONITORING

    5.2 PORTER'S FIVE FORCES MODEL

    5.2.1 BARGAINING POWER OF SUPPLIERS

    5.2.2 BARGAINING POWER OF BUYERS

    5.2.3 THREAT OF NEW ENTRANTS

    5.2.4 THREAT OF SUBSTITUTES

    5.2.5 INTENSITY OF RIVALRY

    5.3 IMPACT OF COVID-19 ON THE MICROARRAY ANALYSIS MARKET

    5.3.1 OVERVIEW

    5.3.2 IMPACT ON SUPPLY CHAIN

    5.3.3 IMPACT ON DEVELOPMENT OF NEW MICROARRAY PRODUCTS FOR MAPPING COVID-19

    6 GLOBAL MICROARRAY ANALYSIS MARKET, BY PRODUCT AND SERVICES

    6.1 OVERVIEW

    6.2 CONSUMABLES

    6.3 SOFTWARE AND SERVICES

    6.4 INSTRUMENTS

    7 GLOBAL MICROARRAY ANALYSIS MARKET, BY TYPE

    7.1 OVERVIEW

    7.2 DNA MICROARRAYS

    7.3 PROTEIN MICROARRAYS

    7.4 OTHERS

    8 GLOBAL MICROARRAY ANALYSIS MARKET, BY APPLICATION

    8.1 OVERVIEW

    8.2 DRUG DISCOVERY

    8.3 DISEASE DIAGNOSTICS

    8.4 RESEARCH APPLICATIONS

    8.5 OTHERS

    9 GLOBAL MICROARRAY ANALYSIS MARKET, BY END USERS

    9.1 OVERVIEW

    9.2 RESEARCH & ACADEMIC INSTITUTES

    9.3 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES

    9.4 DIAGNOSTIC LABORATORIES

    9.5 OTHERS

    10 GLOBAL MICROARRAY ANALYSIS MARKET, BY REGION

    10.1 OVERVIEW

    10.2 AMERICAS

    10.2.1 NORTH AMERICA

    10.2.1.1 U.S.

    10.2.1.2 CANADA

    10.2.2 LATIN AMERICA

    10.3 EUROPE

    10.3.1 WESTERN EUROPE

    10.3.1.1 GERMANY

    10.3.1.2 FRANCE

    10.3.1.3 UK

    10.3.1.4 ITALY

    10.3.1.5 SPAIN

    10.3.1.6 REST OF WESTERN EUROPE

    10.3.2 EASTERN EUROPE

    10.4 ASIA-PACIFIC

    10.4.1 CHINA

    10.4.2 INDIA

    10.4.3 JAPAN

    10.4.4 SOUTH KOREA

    10.4.5 AUSTRALIA

    10.4.6 REST OF ASIA-PACIFIC

    10.5 MIDDLE EAST & AFRICA

    10.5.1 MIDDLE EAST

    10.5.2 AFRICA

    11 COMPETITIVE LANDSCAPE

    11.1 OVERVIEW

    11.2 MARKET SHARE ANALYSIS

    11.3 COMPETITIVE BENCHMARKING

    11.4 MAJOR GROWTH STRATEGY IN THE GLOBAL MICROARRAY ANALYSIS MARKET

    11.5 THE LEADING PLAYER IN TERMS OF NUMBER OF DEVELOPMENTS IN THE GLOBAL MICROARRAY MARKET

    11.6 KEY DEVELOPMENT ANALYSIS

    11.7 KEY DEVELOPMENTS & GROWTH STRATEGIES

    11.7.1 PRODUCT LAUNCHES/PRODUCT APPROVALS

    11.7.2 PARTNERSHIPS/AGREEMENTS

    11.7.3 ACQUISITIONS

    11.7.4 EXPANSIONS

    12 COMPANY PROFILES

    12.1 THERMO FISHER SCIENTIFIC INC.

    12.1.1 COMPANY OVERVIEW

    12.1.2 FINANCIAL OVERVIEW

    12.1.3 PRODUCTS/SERVICES OFFERED

    12.1.4 KEY DEVELOPMENTS

    12.1.5 SWOT ANALYSIS

    12.1.6 KEY STRATEGIES

    12.2 AGILENT TECHNOLOGIES

    12.2.1 COMPANY OVERVIEW

    12.2.2 FINANCIAL OVERVIEW

    12.2.3 PRODUCTS/SERVICES OFFERED

    12.2.4 KEY DEVELOPMENTS

    12.2.5 SWOT ANALYSIS

    12.2.6 KEY STRATEGIES

    12.3 ILLUMINA

    12.3.1 COMPANY OVERVIEW

    12.3.2 FINANCIAL OVERVIEW

    12.3.3 PRODUCTS/SERVICES OFFERED

    12.3.4 KEY DEVELOPMENTS

    12.3.5 SWOT ANALYSIS

    12.3.6 KEY STRATEGIES

    12.4 PERKINELMER, INC

    12.4.1 COMPANY OVERVIEW

    12.4.2 FINANCIAL OVERVIEW

    12.4.3 PRODUCTS/SERVICES OFFERED

    12.4.4 KEY DEVELOPMENTS

    12.4.5 SWOT ANALYSIS

    12.4.6 KEY STRATEGIES

    12.5 MERCK KGAA

    12.5.1 COMPANY OVERVIEW

    12.5.2 FINANCIAL OVERVIEW

    12.5.3 PRODUCTS/SERVICES OFFERED

    12.5.4 KEY DEVELOPMENTS

    12.5.5 SWOT ANALYSIS

    12.5.6 KEY STRATEGIES

    12.6 GE HEALTHCARE

    12.6.1 COMPANY OVERVIEW

    12.6.2 FINANCIAL OVERVIEW

    12.6.3 PRODUCTS/SERVICES OFFERED

    12.6.4 KEY DEVELOPMENTS

    12.6.5 SWOT ANALYSIS

    12.6.6 KEY STRATEGIES

    12.7 DANAHER CORPORATION

    12.7.1 COMPANY OVERVIEW

    12.7.2 FINANCIAL OVERVIEW

    12.7.3 PRODUCTS/SERVICES OFFERED

    12.7.4 KEY DEVELOPMENTS

    12.7.5 SWOT ANALYSIS

    12.7.6 KEY STRATEGIES

    12.8 ARRAYIT CORPORATION

    12.8.1 COMPANY OVERVIEW

    12.8.2 FINANCIAL OVERVIEW

    12.8.3 PRODUCTS/SERVICES OFFERED

    12.8.4 KEY DEVELOPMENTS

    12.8.5 SWOT ANALYSIS

    12.8.6 KEY STRATEGIES

    12.9 BIO-RAD LABORATORIES

    12.9.1 COMPANY OVERVIEW

    12.9.2 FINANCIAL OVERVIEW

    12.9.3 PRODUCTS/SERVICES OFFERED

    12.9.4 KEY DEVELOPMENTS

    12.9.5 SWOT ANALYSIS

    12.9.6 KEY STRATEGIES

    12.10 MICROARRAYS INC.

    12.10.1 COMPANY OVERVIEW

    12.10.2 FINANCIAL OVERVIEW

    12.10.3 PRODUCTS/SERVICES OFFERED

    12.10.4 KEY DEVELOPMENTS

    12.10.5 SWOT ANALYSIS

    12.10.6 KEY STRATEGIES

    13 APPENDIX

    13.1 REFERENCES

    13.2 RELATED REPORTS

    LIST OF TABLES

    TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS

    TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS

    TABLE 3 GLOBAL: MICROARRAY ANALYSIS MARKET, BY PRODUCT AND SERVICES, 2017–2027 (USD MILLION)

    TABLE 4 GLOBAL: MICROARRAY ANALYSIS MARKET, FOR CONSUMABLES, BY REGION, 2017–2027 (USD MILLION)

    TABLE 5 GLOBAL: MICROARRAY ANALYSIS MARKET, FOR SOFTWARE AND SERVICES, BY REGION, 2017–2027 (USD MILLION)

    TABLE 6 GLOBAL: MICROARRAY ANALYSIS MARKET, FOR INSTRUMENTS, BY REGION, 2017–2027 (USD MILLION)

    TABLE 7 GLOBAL: MICROARRAY ANALYSIS MARKET, BY TYPE, 2017–2027 (USD MILLION)

    TABLE 8 GLOBAL: MICROARRAY ANALYSIS MARKET, BY DNA MICROARRAYS, BY REGION, 2017–2027 (USD MILLION)

    TABLE 9 GLOBAL: MICROARRAY ANALYSIS MARKET, BY PROTEIN MICROARRAYS, BY REGION, 2017–2027 (USD MILLION)

    TABLE 10 GLOBAL: MICROARRAY ANALYSIS MARKET, FOR OTHERS, BY REGION, 2017–2027 (USD MILLION)

    TABLE 11 GLOBAL: MICROARRAY ANALYSIS MARKET, BY APPLICATION, 2017–2027 (USD MILLION)

    TABLE 12 GLOBAL: MICROARRAY ANALYSIS MARKET, FOR DRUG DISCOVERY, BY REGION, 2017–2027 (USD MILLION)

    TABLE 13 GLOBAL: MICROARRAY ANALYSIS MARKET, FOR DISEASE DIAGNOSTICS, BY REGION, 2017–2027 (USD MILLION)

    TABLE 14 GLOBAL: MICROARRAY ANALYSIS MARKET, FOR RESEARCH APPLICATIONS, BY REGION, 2017–2027 (USD MILLION)

    TABLE 15 GLOBAL: MICROARRAY ANALYSIS MARKET, FOR OTHERS, BY REGION, 2017–2027 (USD MILLION)

    TABLE 16 GLOBAL: MICROARRAY ANALYSIS MARKET, BY END USERS, 2017–2027 (USD MILLION)

    TABLE 17 GLOBAL: MICROARRAY ANALYSIS MARKET, BY HOSPITALS & CLINICS, BY REGION, 2017–2027 (USD MILLION)

    TABLE 18 GLOBAL: MICROARRAY ANALYSIS MARKET, FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2017–2027 (USD MILLION)

    TABLE 19 GLOBAL: MICROARRAY ANALYSIS MARKET, FOR DIAGNOSTIC LABORATORIES, BY REGION, 2017–2027 (USD MILLION)

    TABLE 20 GLOBAL: MICROARRAY ANALYSIS MARKET, BY OTHERS, BY REGION, 2017–2027 (USD MILLION)

    TABLE 21 GLOBAL: MICROARRAY ANALYSIS MARKET, BY REGION, 2017–2027 (USD MILLION)

    TABLE 22 AMERICAS: MICRROARRAY ANALYSIS MARKET, BY REGION, 2017–2027 (USD MILLION)

    TABLE 23 AMERICAS: MICROARRAY ANALYSIS MARKET, BY PRODUCT AND SERVICE, 2017–2027 (USD MILLION)

    TABLE 24 AMERICAS: MICROARRAY ANALYSIS MARKET, BY TYPE, 2017–2027 (USD MILLION)

    TABLE 25 AMERICAS: MICROARRAY ANALYSIS MARKET, BY APPLICATION, 2017–2027 (USD MILLION)

    TABLE 26 AMERICAS: MICROARRAY ANALYSIS MARKET, BY END USER, 2017–2027 (USD MILLION)

    TABLE 27 NORTH AMERICA: MICROARRAY ANALYSIS MARKET, BY COUNTRY, 2017–2027 (USD MILLION)

    TABLE 28 NORTH AMERICA: MICROARRAY ANALYSIS MARKET, BY PRODUCT AND SERVICE, 2017–2027 (USD MILLION)

    TABLE 29 NORTH AMERICA: MICROARRAY ANALYSIS MARKET, BY TYPE, 2017–2027 (USD MILLION)

    TABLE 30 NORTH AMERICA: MICROARRAY ANALYSIS MARKET, BY APPLICATION, 2017–2027 (USD MILLION)

    TABLE 31 NORTH AMERICA: MICROARRAY ANALYSIS MARKET, BY END USER, 2017–2027 (USD MILLION)

    TABLE 32 US: MICROARRAY ANALYSIS MARKET, BY PRODUCT AND SERVICE, 2017–2027 (USD MILLION)

    TABLE 33 US: MICROARRAY ANALYSIS MARKET, BY TYPE, 2017–2027 (USD MILLION)

    TABLE 34 US: MICROARRAY ANALYSIS MARKET, BY APPLICATION, 2017–2027 (USD MILLION)

    TABLE 35 US: MICROARRAY ANALYSIS MARKET, BY END USER, 2017–2027 (USD MILLION)

    TABLE 36 CANADA: MICROARRAY ANALYSIS MARKET, BY PRODUCT AND SERVICE, 2017–2027 (USD MILLION)

    TABLE 37 CANADA: MICROARRAY ANALYSIS MARKET, BY TYPE, 2017–2027 (USD MILLION)

    TABLE 38 CANADA: MICROARRAY ANALYSIS MARKET, BY APPLICATION, 2017–2027 (USD MILLION)

    TABLE 39 CANADA: MICROARRAY ANALYSIS MARKET, BY END USER, 2017–2027 (USD MILLION)

    TABLE 40 LATIN AMERICA: MICROARRAY ANALYSIS MARKET, BY PRODUCT AND SERVICE, 2017–2027 (USD MILLION)

    TABLE 41 LATIN AMERICA: MICROARRAY ANALYSIS MARKET, BY TYPE, 2017–2027 (USD MILLION)

    TABLE 42 LATIN AMERICA: MICROARRAY ANALYSIS MARKET, BY APPLICATION, 2017–2027 (USD MILLION)

    TABLE 43 LATIN AMERICA: MICROARRAY ANALYSIS MARKET, BY END USER, 2017–2027 (USD MILLION)

    TABLE 44 EUROPE: MICROARRAY ANALYSIS MARKET, BY REGION, 2017–2027 (USD MILLION)

    TABLE 45 EUROPE: MICROARRAY ANALYSIS MARKET, BY PRODUCT AND SERVICE, 2017–2027 (USD MILLION)

    TABLE 46 EUROPE: MICROARRAY ANALYSIS MARKET, BY TYPE, 2017–2027 (USD MILLION)

    TABLE 47 EUROPE: MICROARRAY ANALYSIS MARKET, BY APPLICATION, 2017–2027 (USD MILLION)

    TABLE 48 EUROPE: MICROARRAY ANALYSIS MARKET, BY END USER, 2017–2027 (USD MILLION)

    TABLE 49 WESTERN EUROPE: MICROARRAY ANALYSIS MARKET, BY COUNTRY, 2017–2027 (USD MILLION)

    TABLE 50 WESTERN EUROPE: MICROARRAY ANALYSIS MARKET, BY PRODUCT AND SERVICE, 2017–2027 (USD MILLION)

    TABLE 51 WESTERN EUROPE: MICROARRAY ANALYSIS MARKET, BY TYPE, 2017–2027 (USD MILLION)

    TABLE 52 WESTERN EUROPE: MICROARRAY ANALYSIS MARKET, BY APPLICATION, 2017–2027 (USD MILLION)

    TABLE 53 WESTERN EUROPE: MICROARRAY ANALYSIS MARKET, BY END USER, 2017–2027 (USD MILLION)

    TABLE 54 GERMANY: MICROARRAY ANALYSIS MARKET, BY PRODUCT AND SERVICE, 2017–2027 (USD MILLION)

    TABLE 55 GERMANY: MICROARRAY ANALYSIS MARKET, BY TYPE, 2017–2027 (USD MILLION)

    TABLE 56 GERMANY: MICROARRAY ANALYSIS MARKET, BY APPLICATION, 2017–2027 (USD MILLION)

    TABLE 57 GERMANY: MICROARRAY ANALYSIS MARKET, BY END USER, 2017–2027 (USD MILLION)

    TABLE 58 FRANCE: MICROARRAY ANALYSIS MARKET, BY PRODUCT AND SERVICE, 2017–2027 (USD MILLION)

    TABLE 59 FRANCE: MICROARRAY ANALYSIS MARKET, BY TYPE, 2017–2027 (USD MILLION)

    TABLE 60 FRANCE: MICROARRAY ANALYSIS MARKET, BY APPLICATION, 2017–2027 (USD MILLION)

    TABLE 61 FRANCE: MICROARRAY ANALYSIS MARKET, BY END USER, 2017–2027 (USD MILLION)

    TABLE 62 UK: MICROARRAY ANALYSIS MARKET, BY PRODUCT AND SERVICE, 2017–2027 (USD MILLION)

    TABLE 63 UK: MICROARRAY ANALYSIS MARKET, BY TYPE, 2017–2027 (USD MILLION)

    TABLE 64 UK: MICROARRAY ANALYSIS MARKET, BY APPLICATION, 2017–2027 (USD MILLION)

    TABLE 65 UK: MICROARRAY ANALYSIS MARKET, BY END USER, 2017–2027 (USD MILLION)

    TABLE 66 ITALY: MICROARRAY ANALYSIS MARKET, BY PRODUCT AND SERVICE, 2017–2027 (USD MILLION)

    TABLE 67 ITALY: MICROARRAY ANALYSIS MARKET, BY TYPE, 2017–2027 (USD MILLION)

    TABLE 68 ITALY: MICROARRAY ANALYSIS MARKET, BY APPLICATION, 2017–2027 (USD MILLION)

    TABLE 69 ITALY: MICROARRAY ANALYSIS MARKET, BY END USER, 2017–2027 (USD MILLION)

    TABLE 70 SPAIN: MICROARRAY ANALYSIS MARKET, BY PRODUCT AND SERVICE, 2017–2027 (USD MILLION)

    TABLE 71 SPAIN: MICROARRAY ANALYSIS MARKET, BY TYPE, 2017–2027 (USD MILLION)

    TABLE 72 SPAIN: MICROARRAY ANALYSIS MARKET, BY APPLICATION, 2017–2027 (USD MILLION)

    TABLE 73 SPAIN: MICROARRAY ANALYSIS MARKET, BY END USER, 2017–2027 (USD MILLION)

    TABLE 74 REST OF WESTERN EUROPE: MICROARRAY ANALYSIS MARKET, BY PRODUCT AND SERVICE, 2017–2027 (USD MILLION)

    TABLE 75 REST OF WESTERN EUROPE: MICROARRAY ANALYSIS MARKET, BY TYPE, 2017–2027 (USD MILLION)

    TABLE 76 REST OF WESTERN EUROPE: MICROARRAY ANALYSIS MARKET, BY APPLICATION, 2017–2027 (USD MILLION)

    TABLE 77 REST OF WESTERN EUROPE: MICROARRAY ANALYSIS MARKET, BY END USER, 2017–2027 (USD MILLION)

    TABLE 78 EASTERN EUROPE: MICROARRAY ANALYSIS MARKET, BY PRODUCT AND SERVICE, 2017–2027 (USD MILLION)

    TABLE 79 EASTERN EUROPE: MICROARRAY ANALYSIS MARKET, BY TYPE, 2017–2027 (USD MILLION)

    TABLE 80 EASTERN EUROPE: MICROARRAY ANALYSIS MARKET, BY APPLICATION, 2017–2027 (USD MILLION)

    TABLE 81 EASTERN EUROPE: MICROARRAY ANALYSIS MARKET, BY END USER, 2017–2027 (USD MILLION)

    TABLE 82 ASIA PACIFIC: MICROARRAY ANALYSIS MARKET, BY COUNTRY, 2017–2027 (USD MILLION)

    TABLE 83 ASIA PACIFIC: MICROARRAY ANALYSIS MARKET, BY PRODUCT AND SERVICE, 2017–2027 (USD MILLION)

    TABLE 84 ASIA PACIFIC: MICROARRAY ANALYSIS MARKET, BY TYPE, 2017–2027 (USD MILLION)

    TABLE 85 ASIA PACIFIC: MICROARRAY ANALYSIS MARKET, BY APPLICATION, 2017–2027 (USD MILLION)

    TABLE 86 ASIA PACIFIC: MICROARRAY ANALYSIS MARKET, BY END USER, 2017–2027 (USD MILLION)

    TABLE 87 CHINA: MICROARRAY ANALYSIS MARKET, BY PRODUCT AND SERVICE, 2017–2027 (USD MILLION)

    TABLE 88 CHINA: MICROARRAY ANALYSIS MARKET, BY TYPE, 2017–2027 (USD MILLION)

    TABLE 89 CHINA: MICROARRAY ANALYSIS MARKET, BY APPLICATION, 2017–2027 (USD MILLION)

    TABLE 90 CHINA: MICROARRAY ANALYSIS MARKET, BY END USER, 2017–2027 (USD MILLION)

    TABLE 91 INDIA: MICROARRAY ANALYSIS MARKET, BY PRODUCT AND SERVICE, 2017–2027 (USD MILLION)

    TABLE 92 INDIA: MICROARRAY ANALYSIS MARKET, BY TYPE, 2017–2027 (USD MILLION)

    TABLE 93 INDIA: MICROARRAY ANALYSIS MARKET, BY APPLICATION, 2017–2027 (USD MILLION)

    TABLE 94 INDIA: MICROARRAY ANALYSIS MARKET, BY END USER, 2017–2027 (USD MILLION)

    TABLE 95 JAPAN: MICROARRAY ANALYSIS MARKET, BY PRODUCT AND SERVICE, 2017–2027 (USD MILLION)

    TABLE 96 JAPAN: MICROARRAY ANALYSIS MARKET, BY TYPE, 2017–2027 (USD MILLION)

    TABLE 97 JAPAN: MICROARRAY ANALYSIS MARKET, BY APPLICATION, 2017–2027 (USD MILLION)

    TABLE 98 JAPAN: MICROARRAY ANALYSIS MARKET, BY END USER, 2017–2027 (USD MILLION)

    TABLE 99 SOUTH KOREA: MICROARRAY ANALYSIS MARKET, BY PRODUCT AND SERVICE, 2017–2027 (USD MILLION)

    TABLE 100 SOUTH KOREA: MICROARRAY ANALYSIS MARKET, BY TYPE, 2017–2027 (USD MILLION)

    TABLE 101 SOUTH KOREA: MICROARRAY ANALYSIS MARKET, BY APPLICATION, 2017–2027 (USD MILLION)

    TABLE 102 SOUTH KOREA: MICROARRAY ANALYSIS MARKET, BY END USER, 2017–2027 (USD MILLION)

    TABLE 103 AUSTRALIA: MICROARRAY ANALYSIS MARKET, BY PRODUCT AND SERVICE, 2017–2027 (USD MILLION)

    TABLE 104 AUSTALIA: MICROARRAY ANALYSIS MARKET, BY TYPE, 2017–2027 (USD MILLION)

    TABLE 105 AUSTRALIA: MICROARRAY ANALYSIS MARKET, BY APPLICATION, 2017–2027 (USD MILLION)

    TABLE 106 AUSTRALIA: MICROARRAY ANALYSIS MARKET, BY END USER, 2017–2027 (USD MILLION)

    TABLE 107 REST OF ASIA PACIFIC: MICROARRAY ANALYSIS MARKET, BY PRODUCT AND SERVICE, 2017–2027 (USD MILLION)

    TABLE 108 REST OF ASIA PACIFIC: MICROARRAY ANALYSIS MARKET, BY TYPE, 2017–2027 (USD MILLION)

    TABLE 109 REST OF ASIA PACIFIC: MICROARRAY ANALYSIS MARKET, BY APPLICATION, 2017–2027 (USD MILLION)

    TABLE 110 REST OF ASIA PACIFIC: MICROARRAY ANALYSIS MARKET, BY END USER, 2017–2027 (USD MILLION)

    TABLE 111 MIDDLE EAST & AFRICA: MICROARRAY ANALYSIS MARKET, BY REGION, 2017–2027 (USD MILLION)

    TABLE 112 MIDDLE EAST & AFRICA: MICROARRAY ANALYSIS MARKET, BY PRODUCT AND SERVICE, 2017–2027 (USD MILLION)

    TABLE 113 MIDDLE EAST & AFRICA: MICROARRAY ANALYSIS MARKET, BY TYPE, 2017–2027 (USD MILLION)

    TABLE 114 MIDDLE EAST & AFRICA: MICROARRAY ANALYSIS MARKET, BY APPLICATION, 2017–2027 (USD MILLION)

    TABLE 115 MIDDLE EAST & AFRICA: MICROARRAY ANALYSIS MARKET, BY END USER, 2017–2027 (USD MILLION)

    TABLE 116 MIDDLE EAST: MICROARRAY ANALYSIS MARKET, BY PRODUCT AND SERVICE, 2017–2027 (USD MILLION)

    TABLE 117 MIDDLE EAST: MICROARRAY ANALYSIS MARKET, BY TYPE, 2017–2027 (USD MILLION)

    TABLE 118 MIDDLE EAST: MICROARRAY ANALYSIS MARKET, BY APPLICATION, 2017–2027 (USD MILLION)

    TABLE 119 MIDDLE EAST: MICROARRAY ANALYSIS MARKET, BY END USER, 2017–2027 (USD MILLION)

    TABLE 120 AFRICA: MICROARRAY ANALYSIS MARKET, BY PRODUCT AND SERVICE, 2017–2027 (USD MILLION)

    TABLE 121 AFRICA: MICROARRAY ANALYSIS MARKET, BY TYPE, 2017–2027 (USD MILLION)

    TABLE 122 AFRICA: MICROARRAY ANALYSIS MARKET, BY APPLICATION, 2017–2027 (USD MILLION)

    TABLE 123 AFRICA: MICROARRAY ANALYSIS MARKET, BY END USER, 2017–2027 (USD MILLION)

    TABLE 124 MAJOR MANUFACTURERS IN THE GLOBAL MICROARRAY ANALYSIS MARKET

    TABLE 125 MOST ACTIVE PLAYER IN THE GLOBAL MICROARRAY MARKET

    TABLE 126 PRODUCT LAUNCHES/PRODUCT APPROVALS

    TABLE 127 PARTNERSHIPS/AGREEMENTS

    TABLE 128 ACQUISITIONS

    TABLE 129 EXPANSIONS

    TABLE 130 THERMO FISHER SCIENTIFIC INC.: PRODUCTS/SERVICES OFFERED

    TABLE 131 THERMO FISHER SCIENTIFIC INC.: KEY DEVELOPMENTS

    TABLE 132 AGILENT TECHNOLOGIES: PRODUCTS/SERVICES OFFERED

    TABLE 133 AGILENT TECHNOLOGIES, INC.: KEY DEVELOPMENTS

    TABLE 134 ILLUMINA: PRODUCTS/SERVICES OFFERED

    TABLE 135 ILLUMINA: KEY DEVELOPMENTS

    TABLE 136 PERKINELMER INC.: PRODUCTS/SERVICES OFFERED

    TABLE 137 PERKINELMER INC: KEY DEVELOPMENTS

    TABLE 138 MERCK KGAA.: PRODUCTS/SERVICES OFFERED

    TABLE 139 MERCK KGAA: KEY DEVELOPMENTS

    TABLE 140 GE HEALTHCARE: PRODUCTS/SERVICES OFFERED

    TABLE 141 DANAHER CORPORATION: PRODUCTS/SERVICES OFFERED

    TABLE 142 DANAHER CORPORATION: KEY DEVELOPMENTS

    TABLE 143 ARRAYIT CORPORATION: PRODUCTS/SERVICES OFFERED

    TABLE 144 BIO-RAD LABORATORIES, INC.: PRODUCTS/SERVICES OFFERED

    TABLE 145 BIO-RAD LABORATORIES, INC: KEY DEVELOPMENTS

    TABLE 146 MICROARRAYS INC.: PRODUCTS/SERVICES OFFERED

    LIST OF FIGURES

    FIGURE 1 MARKET SYNOPSIS

    FIGURE 2 MICROARRAY ANALYSIS MARKET STRUCTURE

    FIGURE 3 BOTTOM-UP AND TOP-DOWN APPROACHES

    FIGURE 4 MARKET DYNAMICS: MICROARRAY ANALYSIS MARKET

    FIGURE 5 DRIVER IMPACT ANALYSIS

    FIGURE 6 RESTRAINT IMPACT ANALYSIS

    FIGURE 7 VALUE CHAIN ANALYSIS: MICROARRAY ANALYSIS MARKET

    FIGURE 8 PORTER'S FIVE FORCES ANALYSIS: MICROARRAY ANALYSIS MARKET

    FIGURE 9 GLOBAL MICROARRAY ANALYSIS MARKET, BY PRODUCT AND SERVICES, 2019 & 2027 (USD MILLION)

    FIGURE 10 GLOBAL: MICROARRAY ANALYSIS MARKET, BY TYPE, 2019 & 2027 (USD MILLION)

    FIGURE 11 GLOBAL: MICROARRAY ANALYSIS MARKET, BY APPLICATION, 2019 & 2027 (USD MILLION)

    FIGURE 12 GLOBAL: MICROARRAY ANALYSIS MARKET, END USERS, 2019 & 2027 (USD MILLION)

    FIGURE 13 GLOBAL: MICROARRAY ANALYSIS MARKET, BY REGION 2019 & 2027 (USD MILLION)

    FIGURE 14 GLOBAL: MICROARRAY ANALYSIS MARKET SHARE, BY REGION 2019 (%)

    FIGURE 15 AMERICAS: MICRROARRAY ANALYSIS MARKET SHARE, BY REGION 2019 (%)

    FIGURE 16 NORTH AMERICA: MICROARRAY ANALYSIS MARKET SHARE, BY COUNTRY 2019 (%)

    FIGURE 17 EUROPE: MICROARRAY ANALYSIS MARKET SHARE, BY REGION 2019 (%)

    FIGURE 18 WESTERN EUROPE: MICROARRAY ANALYSIS MARKET SHARE, BY COUNTRY 2019 (%)

    FIGURE 19 ASIA PACIFIC: MICROARRAY ANALYSIS MARKET SHARE, BY COUNTRY 2019 (%)

    FIGURE 20 MIDDLE EAST & AFRICA: MICROARRAY ANALYSIS MARKET SHARE, BY REGION 2019 (%)

    FIGURE 21 MARKET SHARE ANALYSIS OF KEY PLAYERS IN THE GLOBAL MICROARRAY ANALYSIS MARKET (%)

    FIGURE 22 BENCHMARKING OF MAJOR COMPETITORS

    FIGURE 23 MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN THE GLOBAL MICROARRAY ANALYSIS MARKET

    FIGURE 24 GLOBAL MCIROARRAY ANALYSIS MARKET: COMPETITIVE LANDSCAPE

    FIGURE 25 THERMO FISHER SCIENTIFIC INC.: FINANCIAL OVERVIEW SNAPSHOT

    FIGURE 26 THERMO FISHER SCIENTIFIC INC.: SWOT ANALYSIS

    FIGURE 27 AGILENT TECHNOLOGIES: FINANCIAL OVERVIEW SNAPSHOT

    FIGURE 28 AGILENT TECHNOLOGIES, INC. SWOT ANALYSIS

    FIGURE 29 ILLUMINA: FINANCIAL OVERVIEW SNAPSHOT

    FIGURE 30 ILLUMINA: SWOT ANALYSIS

    FIGURE 31 PERKINELMER, INC.: FINANCIAL OVERVIEW SNAPSHOT

    FIGURE 32 PERKINELMER INC: SWOT ANALYSIS

    FIGURE 33 MERCK KGAA: FINANCIAL OVERVIEW SNAPSHOT

    FIGURE 34 MERCK KGAA: SWOT ANALYSIS

    FIGURE 35 GE HEALTHCARE: FINANCIAL OVERVIEW SNAPSHOT

    FIGURE 36 GE HEALTHCARE: SWOT ANALYSIS

    FIGURE 37 DANAHER CORPORATION: FINANCIAL OVERVIEW SNAPSHOT

    FIGURE 38 DANAHER CORPORATION: SWOT ANALYSIS

    FIGURE 39 ARRAYIT CORPORATION: SWOT ANALYSIS

    FIGURE 40 BIO-RAD LABORATORIES, INC: FINANCIAL OVERVIEW SNAPSHOT

    FIGURE 41 BIO-RAD LABORATORIES, INC: SWOT ANALYSIS

    FIGURE 42 MICROARRAYS INC.: SWOT ANALYSIS



    This table of content is tentative and subject to change as the research progresses.

    Please Note:  Financial details of company cannot be provided if the information of the company is not available in public domain and or reliable source.